Intracoronary and intravenous administration of basic fibroblast growth factor: Myocardial and tissue distribution

Drug Metabolism and Disposition

Volumn 27, Issue 7, 1999, Pages 821-826

  Laham, Roger J ^a,c   Rezaee, Mehrdad ^a   Post, Mark ^a   Sellke, Frank W ^a   Braeckman, Rene A ^b   Hung, David ^b   Simons, Michael ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HEPARIN; IODINE 125;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DRUG TISSUE LEVEL; FEMALE; HEART MUSCLE; INTRACARDIAC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALS; DRUG ADMINISTRATION ROUTES; FIBROBLAST GROWTH FACTOR 2; HEART; INFUSIONS, INTRAVENOUS; KIDNEY; MYOCARDIUM; SWINE; TISSUE DISTRIBUTION;

ANIMALIA; SUS SCROFA;

EID: 0033034205     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA and Park JE (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487.
2. Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF and Isner JM (1995) Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92(Suppl II):365-371.
3. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE and Unger EF (1994a) Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89:2183-2189.
4. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G and Keshet E (1994b) Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: Implications for coronary angiogenesis. Cardiovasc Res 28:1176-1179.
5. Battler A, Scheinowitz M, Bor A, Hasdai D, Vered Z, Di Segni E, Varda-Bloom N, Nass D, Engelberg S and Eldar M (1993) Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium. J Am Coll Cardiol 22:2001-2006.
6. Boulton M, Gregor Z, McLeod D, Charteris D, Jarvis-Evans J, Moriarty P, Khaliq A, Foreman D, Allamby D and Bardsley B (1997) Intravitreal growth factors in proliferative diabetic retinopathy: Correlation with neovascular activity and glycaemic management. Br J Ophthalmol 81:228-233.
7. Charney R and Cohen M (1993) The role of the coronary collateral circulation in limiting myocardial ischemia and infarct size. Am Heart J 126:937-945.
8. Di Carli M, Sherman T, Khanna S, Davidson M, Rokhsar S, Hawkins R, Phelps M, Schelbert H and Maddahi J (1994) Myocardial viability in asynergic regions subtended by occluded coronary arteries: Relation to the status of collateral flow in patients with chronic coronary artery disease. J Am Coll Cardiol 23:860-868.
9. Edelman ER, Nugent MA and Karnovsky MJ (1993) Perivascular and intravenous administration of basic fibroblast growth factor: Vascular and solid organ deposition. Proc Natl Acad Sci USA 90:1513-1517.
10. Favard C, Ortega N, Bayard F and Plouet J (1996) Vascular endothelial growth factor and retinal neovascularisation: A new therapeutic approach for diabetic retinopathy. Diabetes Metab 22:268-273.
11. Fujita M, Ikemoto M, Kishishita M, Otani H, Nohara R, Tanaka T, Tamaki S, Yamazato A and Sasayama S (1996) Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation 94:610-613.
12. Gabra N, Khayat A, Calabresi P and Khiat A (1994) Detection of elevated basic fibroblast growth factor during early hours of in vitro angiogenesis using a fast ELISA immunoassay. Biochem Biophys Res Commun 205:1423-1430.
13. Harada K, Friedman M, Lopez JJ, Wang SY, Li J, Prasad PV, Pearlman JD, Edelman ER, Sellke FW and Simons M (1996) Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol 270:H1791-H1802.
14. Harada K, Grossman W, Friedman M, Edelman ER, Prasad PV, Keighley CS, Manning WJ, Sellke FW and Simons M (1994) Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 94:623-630.
15. Hasdai D, Barak V, Leibovitz E, Herz I, Sclarovsky S, Eldar M and Scheinowitz M (1997) Serum basic fibroblast growth factor levels in patients with ischemic heart disease. Int J Cardiol 59:133-138.
16. Henry T, Rocha-Singh K, Isner J, Kereiakes D, Giordano F, Simons M, Losordo D, Hendel R, Bonow R, Rothman J, Borbas E and McCluskey E (1998) Results of intracoronary recombinant human vascular endothelial growth factor (rhVEGF) administration trial. J Am Coll Cardiol 31:65A.
17. Ibukiyama C (1996) Angiogenesis. Angiogenic therapy using fibroblast growth factors and vascular endothelial growth factors for ischemic vascular lesions. Jpn Heart J 37:285-300.
18. Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K and Symes JF (1996) Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348:370-374.
19. Ladoux A and Frelin C (1993) Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun 195:1005-1010.
20. Laham R, Leimbach M, Chronos N, Vansant J, Pearlman J, Pettigrew R, Guler H, Whitehouse M, Hung D, Baim D, King S and Simons M (1999) Intracoronary administration of recombinant fibroblast growth factor-2 (rFGF-2) in patients with severe coronary artery disease: Results of phase I. J Am Coll Cardiol 33:383A.
21. Laham R, Sellke F, Edelman J and Simons M (1998) Local perivascular basic fibroblast growth factor (bFGF) treatment in patients with ischemic heart disease. J Am Coll Cardiol 31:394A.
22. Laham R and Simons M (1999) Therapeutic angiogenesis in myocardial ischemia, in Angiogenesis and Cardiovascular Disease (Simons W ed) pp 289-320, Oxford University Press, New York.
23. LaMarre J, Wollenberg GK, Gonias SL and Hayes MA (1991) Cytokine binding and clearance properties of proteinase-activated alpha 2-macroglobulins. Lab Invest 65:3-14.
24. Lazarous DF, Scheinowitz M, Shou M, Hodge E, Rajanayagam S, Hunsberger S, Robison WG Jr, Stiber JA, Correa R, Epstein SE and Unger E (1995) Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 91:145-153.
25. Lazarous DF, Shou M, Scheinowitz M, Hodge E, Thirumurti V, Kitsiou AN, Stiber JA, Lobo AD, Hunsberger S, Guetta E, Epstein SE and Unger EF (1996) Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 94:1074-1082.
26. Lazarous DF, Shou M, Stiber JA, Dadhania DM, Thirumurti V, Hodge E and Unger EF (1997) Pharmacodynamics of basic fibroblast growth factor: Route of administralion determines myocardial and systemic distribution. Cardiovasc Res 36:78-85.
27. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP and Simons M (1996) VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 270: H1803-H1811.
28. Muhlhauser J, Pili R, Merrill MJ, Maeda H, Passaniti A, Crystal RG and Capogrossi MC (1995) In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or nonsecreted forms of acidic fibroblast growth factor. Hum Gene Ther 6:1457-1465.
29. Paques M, Massin P and Gaudric A (1997) Growth factors and diabetic retinopathy. Diabetes Metab 23:125-130.
30. Pearlman JD, Hibberd MG, Chuang ML, Harada K, Lopez JJ, Gladstone SR, Friedman M, Sellke FW and Simons M (1995) Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1:1085-1089.
31. Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M and Fukui M (1995) Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55:1189-1193.
32. Schaper W (1996) Collateral vessel growth in the human heart. Role of fibroblast growth factor-2. Circulation 94:600-601.
33. Sellke FW, Li J, Stamler A, Lopez JJ, Thomas KA and Simons M (1996) Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia. Surgery 120:182-188.
34. Sellke FW, Tofukuji M, Laham RJ, Li J, Hariawala MD, Bunting S and Simons M (1998) Comparison of VEGF delivery techniques on collateral-dependent microvascular reactivity. Microvasc Res 55: 175-178.
35. Shinohara K, Shinohara T, Mochizuki N, Mochizuki Y, Sawa H, Kohya T, Fujita M, Fujioka Y, Kitabatake A and Nagashima K (1996) Expression of vascular endothelial growth factor in human myocardial infarction. Heart Vessels 11:113-122.
36. Slavin J (1995) Fibroblast growth factors: At the heart of angiogenesis. Cell Biol Int 19:431-444.
37. Stone DA, Corretti MC, Hawke MW, Herzog W, Rodriguez S and Plotnick GD (1995) The influence of angiographically demonstrated coronary collaterals on the results of stress echocardiography. Clin Cardiol 18:205-208.
38. Whalen GF, Shing Y and Folkman J (1989) The fate of intravenously administered bFGF and the effect of heparin. Growth Factors 1:157-164.
39. Yang HT, Deschenes MR, Ogilvie RW and Terjung RL (1996) Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ Res 79:62-69.
40. Yoshiji H, Gomez DE, Shibuya M and Thorgeirsson UP (1996) Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res 56:2013-2016.